Nothing Stops Innovation.

Biotech Companies Respond to COVID-19
COVID-19

Biotechnology and biopharmaceutical companies are responding to COVID-19 (Coronavirus) with vaccines and anti-viral medications. The science moving faster than ever to get treatments to patients.

Welcome Dr. Michelle McMurry-Heath
Dr. Michelle McMurry-Heath
Dr. Michelle McMurry-Heath's Message to BIO Members and Stakeholders
Dr. Michelle McMurry-Heath Question
1 Minute with Michelle: Why BIO?
1 Minute with Michelle
Why are patients so important to drug discovery?
1 Minute with Michelle- How will you foster collaboration to advance science.png
1 Minute with Michelle: How will you foster collaboration to advance science?
Sign up below to get the Good Day BIO newsletter

Sign-up to receive the Good Day BIO newsletter, the only daily newsletter at the intersection of biotech, politics and policy. 

 
GDB-Signup
Latest From I AM BIO Podcast
IamBIO-Epd-16-Herd-Immunity
“Herd” Immunity (Redux)

Biotech companies are working feverishly to develop antibody therapies to provide short-term protection against COVID-19. But what if the novel coronavirus mutates and outwits traditional monoclonal antibodies? Well, that’s where the super cows come in.

Subscribe on: Apple Podcasts, Google Podcasts, Spotify, or your player of choice.

Featured Events

Online and Live
July 22-26, 2020
Taipei, Taiwan

Sessions available on-demand until July 11 - there's still time to register and catch up!

September 21 - 22, 2020
Online Interactive Conference

Read More. Learn More. Innovate More.
Connect. Learn. Advocate. Innovate. Become a part of BIO.

Our organization champions biotechnology and advocates for our members who range from startups to Fortune 500. Learn more about our member benefits or simply click the button below to join us today!